Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Clin Endocrinol Metab ; 108(8): 1968-1980, 2023 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-36740954

RESUMEN

CONTEXT: Nicotinamide adenine dinucleotide (NAD) levels decline with aging and age-related decline in NAD has been postulated to contribute to age-related diseases. OBJECTIVE: We evaluated the safety and physiologic effects of NAD augmentation by administering its precursor, ß-nicotinamide mononucleotide (MIB-626, Metro International Biotech, Worcester, MA), in adults at risk for age-related conditions. METHODS: Thirty overweight or obese adults, ≥ 45 years, were randomized in a 2:1 ratio to 2 MIB-626 tablets each containing 500 mg of microcrystalline ß-nicotinamide mononucleotide or placebo twice daily for 28 days. Study outcomes included safety; NAD and its metabolome; body weight; liver, muscle, and intra-abdominal fat; insulin sensitivity; blood pressure; lipids; physical performance, and muscle bioenergetics. RESULTS: Adverse events were similar between groups. MIB-626 treatment substantially increased circulating concentrations of NAD and its metabolites. Body weight (difference -1.9 [-3.3, -0.5] kg, P = .008); diastolic blood pressure (difference -7.01 [-13.44, -0.59] mmHg, P = .034); total cholesterol (difference -26.89 [-44.34, -9.44] mg/dL, P = .004), low-density lipoprotein (LDL) cholesterol (-18.73 [-31.85, -5.60] mg/dL, P = .007), and nonhigh-density lipoprotein cholesterol decreased significantly more in the MIB-626 group than placebo. Changes in muscle strength, muscle fatigability, aerobic capacity, and stair-climbing power did not differ significantly between groups. Insulin sensitivity and hepatic and intra-abdominal fat did not change in either group. CONCLUSIONS: MIB-626 administration in overweight or obese, middle-aged and older adults safely increased circulating NAD levels, and significantly reduced total LDL and non-HDL cholesterol, body weight, and diastolic blood pressure. These data provide the rationale for larger trials to assess the efficacy of NAD augmentation in improving cardiometabolic outcomes in older adults.


Asunto(s)
Resistencia a la Insulina , Sobrepeso , Persona de Mediana Edad , Humanos , Anciano , NAD/metabolismo , NAD/uso terapéutico , Mononucleótido de Nicotinamida/uso terapéutico , Obesidad , Peso Corporal , Colesterol
2.
Sensors (Basel) ; 21(16)2021 Aug 06.
Artículo en Inglés | MEDLINE | ID: mdl-34450770

RESUMEN

Smuggling of drugs and cigarettes in small inflatable boats across border rivers is a serious threat to the EU's financial interests. Early detection of such threats is challenging due to difficult and changing environmental conditions. This study reports on the automatic detection of small inflatable boats and people in a rough wild terrain in the infrared thermal domain. Three acquisition campaigns were carried out during spring, summer, and fall under various weather conditions. Three deep learning algorithms, namely, YOLOv2, YOLOv3, and Faster R-CNN working with six different feature extraction neural networks were trained and evaluated in terms of performance and processing time. The best performance was achieved with Faster R-CNN with ResNet101, however, processing requires a long time and a powerful graphics processing unit.


Asunto(s)
Aprendizaje Profundo , Algoritmos , Diagnóstico Precoz , Humanos , Redes Neurales de la Computación , Navíos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA